150 related articles for article (PubMed ID: 37828612)
21. [Reversal of Drug Resistance in K562/ADM Cells Caused by RA and the Related Mechanisms].
Zhong SS; Yuan YP; Xin LY; Chen YJ; Zhang LQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1704-1709. PubMed ID: 34893097
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
23. [siRNA silences mdr1 gene expression and reverses apoptosis resistance of K562/ADM cells line].
Wei HL; Gao LP; Jing T; Zhao HS; Yi J; Sun J; Han J
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):388-90. PubMed ID: 17939404
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.
Zhai BJ; Shao ZY; Zhao CL; Hu K; Wu F
World J Gastroenterol; 2006 Nov; 12(41):6614-9. PubMed ID: 17075973
[TBL] [Abstract][Full Text] [Related]
25. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
[TBL] [Abstract][Full Text] [Related]
26. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
27. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
[TBL] [Abstract][Full Text] [Related]
28. [Reversal of adriamycin resistance of hepatocellular carcinoma by targeting it with recombined adenovirus carrying antisense multidrug resistance gene 1 RNA].
Mei Y; Shi YJ; Ding X; Wu CX; Jian HG; Gong JP; Liu CA
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):199-203. PubMed ID: 17407711
[TBL] [Abstract][Full Text] [Related]
29. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
30. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
[TBL] [Abstract][Full Text] [Related]
31. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
32. Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin.
Tomida A; Naito M; Tsuruo T
Jpn J Cancer Res; 1995 Feb; 86(2):224-32. PubMed ID: 7730148
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Choy E; Hornicek FJ; Mankin H; Milane L; Amiji MM; Duan Z
PLoS One; 2010 May; 5(5):e10764. PubMed ID: 20520719
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑145 promotes the apoptosis of leukemic stem cells and enhances drug‑resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1.
Wuxiao Z; Wang H; Su Q; Zhou H; Hu M; Tao S; Xu L; Chen Y; Hao X
Int J Mol Med; 2020 Oct; 46(4):1289-1300. PubMed ID: 32945355
[TBL] [Abstract][Full Text] [Related]
35. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
36. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
Wang Z; Yang L; Xia Y; Guo C; Kong L
Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
[TBL] [Abstract][Full Text] [Related]
37. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
38. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
Ma X; Zhou X; Qu H; Ma Y; Yue Z; Shang W; Wang P; Xie S; Li Y; Sun Y
Oncol Rep; 2018 Apr; 39(4):1910-1918. PubMed ID: 29436678
[TBL] [Abstract][Full Text] [Related]
39. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro.
Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
Wang Z; Wang C; Zuo D; Zhang T; Yin F; Zhou Z; Wang H; Xu J; Mao M; Wang G; Hua Y; Sun W; Cai Z
Int J Biol Sci; 2019; 15(3):668-679. PubMed ID: 30745853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
